Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health products for medical and industrial use in China and internationally. It operates in three segments: Health Protection Division; Safety Infusion Division; and Innovation Incubation Division. The Health Protection Division offers nitrile gloves… Read more
Zhonghong Pulin Medical Products Co. Ltd. (300981) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.008x
Based on the latest financial reports, Zhonghong Pulin Medical Products Co. Ltd. (300981) has a cash flow conversion efficiency ratio of -0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-44.36 Million) by net assets (CN¥5.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhonghong Pulin Medical Products Co. Ltd. - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhonghong Pulin Medical Products Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhonghong Pulin Medical Products Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LH Shopping Centers Leasehold
BK:LHSC
|
0.011x |
|
Zheshang Development Group Co Ltd
SHE:000906
|
-0.209x |
|
Bombay Burmah Trading Corporation Limited
NSE:BBTC
|
0.039x |
|
Blockchain Group SA
PA:ALTBG
|
0.070x |
|
Enel Generación Chile S.A
SN:ENELGXCH
|
84.843x |
|
Energiekontor AG
F:EKT
|
-0.007x |
|
Ranger Energy Services Inc
NYSE:RNGR
|
0.050x |
|
Abacus Group
AU:ABG
|
0.026x |
Annual Cash Flow Conversion Efficiency for Zhonghong Pulin Medical Products Co. Ltd. (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.62 Billion | CN¥183.91 Million | 0.033x | +37.58% |
| 2023-12-31 | CN¥5.92 Billion | CN¥140.68 Million | 0.024x | +36.68% |
| 2022-12-31 | CN¥6.13 Billion | CN¥106.71 Million | 0.017x | -95.17% |
| 2021-12-31 | CN¥6.55 Billion | CN¥2.36 Billion | 0.360x | -66.13% |
| 2020-12-31 | CN¥2.56 Billion | CN¥2.72 Billion | 1.064x | +169.91% |
| 2019-12-31 | CN¥467.67 Million | CN¥184.38 Million | 0.394x | +523.91% |
| 2018-12-31 | CN¥376.10 Million | CN¥23.77 Million | 0.063x | -78.95% |
| 2017-12-31 | CN¥319.89 Million | CN¥96.03 Million | 0.300x | -25.15% |
| 2016-12-31 | CN¥255.25 Million | CN¥102.37 Million | 0.401x | -16.73% |
| 2015-12-31 | CN¥191.49 Million | CN¥92.23 Million | 0.482x | -45.34% |
| 2014-12-31 | CN¥151.32 Million | CN¥133.33 Million | 0.881x | +727.53% |
| 2013-12-31 | CN¥125.53 Million | CN¥13.37 Million | 0.106x | -- |